Modern Myeloma Therapy plus Sustained Minimal Residual Disease-Negative = (Functional) Cure

Journal article

Open access

Peer reviewed

Journal of clinical oncology, Vol.40(25), p.2863

2022-09-01

PMID: 35772041

Abstract

Life Sciences & Biomedicine

Oncology

Science & Technology

url

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00622View

Published (Version of record) Open

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Modern Myeloma Therapy plus Sustained Minimal Residual Disease-Negative = (Functional) Cure
Creators: Ola Landgren - Sylvester Comprehensive Cancer Center
Dickran Kazandjian - Sylvester Comprehensive Cancer Center
Publication Details: Journal of clinical oncology, Vol.40(25), p.2863
Publisher: Lippincott Williams & Wilkins
Number of pages: 5
Grant note: P30 CA240139 / Sylvester Comprehensive Cancer Center Core Grant Paula and Rodger Riney Foundation
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 35772041
Record Identifier: 991031757965802976